Delivery Order SPE2DB22D3501-SPE2DB24FWK56
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,727,588 units of Valganciclovir 450 mg tablets. The $21,045.78 firm-fixed-price delivery order has a completion date of December 17, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,951.32 firm fixed-price contract is for the delivery of valganciclovir hydrochloride 50 mg/mL oral solution. The ultimate completion date is November 14, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order for $2,356.52 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for valganciclovir hydrochloride 50 mg/mL oral solution, with an ultimate completion date of August 21, 2024. The contract is a firm-fixed price type with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,372.02 Firm Fixed Price Delivery Order is for the supply of Valganciclovir Hydrochloride 50 mg/mL 88 mL medication. The contract has an ultimate completion date of September 3, 2024. No set-aside was used for this award. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.08 firm fixed-price delivery order is for the supply of 4563033480 - Valganciclovir HCL 50 MG/ML 88ML, with a period of performance ending on December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,191.37, is for the delivery of valganciclovir hydrochloride, a pharmaceutical product used in the treatment of certain medical conditions. The contract has a period of performance through May 7, 2024, and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The $8,386.87 firm fixed-price delivery order is for 60 tablets of the medication valganciclovir 450 mg. The contract has a period of performance through July 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count bottles of the drug Valganciclovir 450 mg tablets, with a ceiling value of $3,193.93 and a period of performance through April 14, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...